The endothelial marker CD 34 in the assessment of tumour vascularisation in ovarian cancer

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3149-3151

  Heimburg, S ^a,b   Oehler, M K ^a   Kristen, P ^a   Papadopoulos, T ^a   Caffier, H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Angiogenesis; CD 34; Ovarian cancer

Indexed keywords

CD34 ANTIGEN; MONOCLONAL ANTIBODY;

ANGIOGENESIS; ANTIGEN EXPRESSION; CLINICAL ARTICLE; CONFERENCE PAPER; CONNECTIVE TISSUE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANTIGENS, CD34; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PILOT PROJECTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030800680     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Weidner N, Folkman J, Pozza F, Bevilaqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor Angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992.
2. Obermair A, Czerwenka K, Kurz C, Buxbaum P, Schemper M, Sevelda P: Influence of Tumoral Microvessel Density on the Recurrence-Free Survival in Human Breast Cancer: Preliminary Results. Onkologie 17: 44-49, 1994.
3. Ellis LM, Fidler IJ: Angiogenesis and breast cancer metastasis. Lancet 346: 388-389, 1995.
4. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Plama P, Caffo O, Barbareschi M, Boracchi P, Maribini E, Pozza F: Tumor microvessel density, p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466, 1994.
5. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris A: Angiogenesis, assessed by plateled endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992.
6. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA: Relation of neovascularisation to metastasis of nonsmall-cell lung cancer. Lancet 340: 145-146, 1992.
7. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor Angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993.
8. Trawek ST, Kandalaft PL, Mehta P, Battifora H: The human hematopoietic progenitor cell antigen (CD 34) in vascular neoplasia. Am J Clin Pathol 96: 25-31, 1991.
9. Miettinen M, Lindenmayer E, Chaubal A: Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigene evaluation of their specifity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand Factor. Modern Pathology 7(1): 82-90, 1994.
10. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
11. Weidner N: Intratumor Microvessel Density as a Prognostic Factor in Cancer. Am J Path 147: 9-19, 1995.
12. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ: Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Path 147: 33-41, 1995.